Emerging treatments for HER2-positive early-stage breast cancer: focus on neratinib

Over the last decades, a better understanding of breast cancer heterogeneity provided tools for a biologically based personalization of anticancer treatments. In particular, the overexpression of the human epidermal growth factor receptor 2 (HER2) by tumor cells provided a specific target in these H...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Onco Targets Ther
Main Authors: Kourie, Hampig Raphael, El Rassy, Elie, Clatot, Florian, de Azambuja, Evandro, Lambertini, Matteo
Format: Artigo
Sprog:Inglês
Udgivet: Dove Medical Press 2017
Fag:
Review
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5513878/
https://ncbi.nlm.nih.gov/pubmed/28744140
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S122397
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker